ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED

Zhong Yuan Bio-Technology Holdings Limited

ZHYBF

KYG989A31097

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:40:31 2024-04-26 am EDT			5-day change	1st Jan Change
5 ^USD	0.00%		-0.40%	+146.31%

Mar. 25	Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023

July 27, 2023 at 12:13 pm EDT

Zhong Yuan Bio-Technology Holdings Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was USD 1.66 million compared to USD 2.33 million a year ago. Net loss was USD 2.23 million compared to USD 1.13 million a year ago.

Latest news about Zhong Yuan Bio-Technology Holdings Limited

Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Mar. 25	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-10-06	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-27	CI
Zhong Yuan Bio-Technology Holdings Limited Announces Board Changes	23-06-28	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022	23-02-13	CI
Zhong Yuan Bio-Technology Holdings Limited has filed an IPO.	22-10-25	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-09-26	CI
Zhong Yuan Bio-Technology Holdings Limited Announces Directorate Changes	22-08-04	CI
Zhong Yuan Bio-Technology Holdings Limited Announces Directorate Changes	22-08-04	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2021	22-02-14	CI
Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2021	21-08-16	CI

Chart Zhong Yuan Bio-Technology Holdings Limited

Duration

Period

Chart Zhong Yuan Bio-Technology Holdings Limited

More charts

Company Profile

Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED	+146.31%	88.5M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B